Henrik Szőke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Henrik Szőke has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Jan Vagedes
ARCIM Institute, Filderstadt-Bonlanden, Germany
7 shared publications Jan Vagedes
Department of Neonatology, University-Hospital, Tuebingen University
4 shared publications- Katrin Vagedes
ARCIM Institute, Filderstadt, Germany
4 shared publications - Silja Kuderer
ARCIM Institute, Filderstadt, Germany
4 shared publications Anikó Balogh
School of Social Sciences and Mannheim Business School, University of Mannheim
3 shared publications- David D. Martin
University of Witten/Herdecke
2 shared publications
Latest Publications
- Open Access
- 9 April 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1757745
Integrative evidence-informed management of feverish illnesses in childhood—outcomes of the public FeverFriend prospective app registry
Background: In conventional mainstream practice there is a prevailing negative attitude towards fever, which persists despite the evidence of beneficial immunological effects and lack of practical implementation of this knowledge into the healthcare system. Integrative approaches represent an added value in promoting behavioral change towards supportive fever management. We examined associations between use of the FeverFriend ® app and caregiver-reported antibiotic and antipyretic use and healthcare utilization for febrile illnesses in children. Methods: Prospective patient registry within a mobile app, including a decision aid, connected with a knowledge base. Recruitment and data collection were conducted continuously throughout the study period from 01 December 2020 to 1 September 2025. In this publication we evaluate Hungarian users’ data. The study population ranged from otherwise healthy individuals to patients with chronic diseases, aged between 0 and 18 years. There were no pre-specified groups or subgroups assigned to receive specific intervention(s) (or no intervention) based on the study protocol. Results: In total, 24,371 caregivers registered 26,042 children. Caregivers recorded 17,994 illness episodes and 31,874 temperature measurements; 7,377 episodes included a completed end-of-illness review. Paired analyses were based on children with both baseline and reviewed-episode data. Caregiver-reported antibiotic use, antipyretic use, and doctor consultation were lower in the reviewed episode than in baseline recall (McNemar test with continuity correction, all p < 0.001). Conclusion: FeverFriend registry data are consistent with an association between app use and lower episode-level reporting of antibiotics, antipyretics, and doctor visits compared with 12-month baseline recall.
- 9 April 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1757745
Open AccessIntegrative evidence-informed management of feverish illnesses in childhood—outcomes of the public FeverFriend prospective app registry
Background: In conventional mainstream practice there is a prevailing negative attitude towards fever, which persists despite the evidence of beneficial immunological effects and lack of practical implementation of this knowledge into the healthcare system. Integrative approaches represent an added value in promoting behavioral change towards supportive fever management. We examined associations between use of the FeverFriend ® app and caregiver-reported antibiotic and antipyretic use and healthcare utilization for febrile illnesses in children. Methods: Prospective patient registry within a mobile app, including a decision aid, connected with a knowledge base. Recruitment and data collection were conducted continuously throughout the study period from 01 December 2020 to 1 September 2025. In this publication we evaluate Hungarian users’ data. The study population ranged from otherwise healthy individuals to patients with chronic diseases, aged between 0 and 18 years. There were no pre-specified groups or subgroups assigned to receive specific intervention(s) (or no intervention) based on the study protocol. Results: In total, 24,371 caregivers registered 26,042 children. Caregivers recorded 17,994 illness episodes and 31,874 temperature measurements; 7,377 episodes included a completed end-of-illness review. Paired analyses were based on children with both baseline and reviewed-episode data. Caregiver-reported antibiotic use, antipyretic use, and doctor consultation were lower in the reviewed episode than in baseline recall (McNemar test with continuity correction, all p < 0.001). Conclusion: FeverFriend registry data are consistent with an association between app use and lower episode-level reporting of antibiotics, antipyretics, and doctor visits compared with 12-month baseline recall.
- Open Access
- 3 December 2025
- Published by Elsevier in European Journal of Integrative Medicine
- Vol. 81
The effectiveness and safety of GeloMyrtol® forte in the treatment of acute and chronic bronchitis: A rapid review of clinical studies
- 3 December 2025
- Published by Elsevier in European Journal of Integrative Medicine
- Vol. 81
Open AccessThe effectiveness and safety of GeloMyrtol® forte in the treatment of acute and chronic bronchitis: A rapid review of clinical studies
- Open Access
- 17 January 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (1) , 102
The Introduction of the Global Traditional, Complementary, and Integrative Healthcare (TCIH) Research Agenda on Antimicrobial Resistance and Its Added Value to the WHO and the WHO/FAO/UNEP/WOAH 2023 Research Agendas on Antimicrobial Resistance
Background/Objectives: Given the magnitude and urgency of the global antimicrobial resistance (AMR) problem and the insufficiency of strategies to reduce antimicrobial use, there is a need for novel strategies. Traditional, Complementary, and Integrative Healthcare (TCIH) provides strategies and solutions that contribute to reducing (inappropriate) antimicrobial use, preventing or treating infections in both human and veterinary medicine, and may contribute to promoting the health/resilience of humans and animals and reducing AMR. The aims of this study were to present the core results of a global TCIH research agenda for AMR and its added value to two existing global AMR research agendas published in 2023. Methods: A survey, interviews, and consensus meetings among network members, as an adapted version of the nominal group technique, were executed to develop the global TCIH research agenda. A comparison of the global TCIH research agenda with the two existing global AMR research agendas was performed. The TCIH additions to these two existing global AMR research agendas were determined. Results: The global TCIH research agenda adds to 19 of 40 research priorities of the World Health Organization (WHO) AMR research agenda 2023 and three of the five pillars of the WHO/Food and Agriculture Organization of the United Nations (FAO)/United Nations Environment Programme (UNEP)/World Organisation for Animal Health (WOAH) research agenda 2023. In addition, the TCIH research agenda adds two new research themes with four new research priorities and three new research priorities to already existing themes of the two global AMR research agendas. Conclusions: The global TCIH research agenda fits with and adds to two global AMR research agendas and can be used as an additional strategy to reduce AMR and (inappropriate) use of antibiotics.
- 17 January 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (1) , 102
Open AccessThe Introduction of the Global Traditional, Complementary, and Integrative Healthcare (TCIH) Research Agenda on Antimicrobial Resistance and Its Added Value to the WHO and the WHO/FAO/UNEP/WOAH 2023 Research Agendas on Antimicrobial Resistance
Background/Objectives: Given the magnitude and urgency of the global antimicrobial resistance (AMR) problem and the insufficiency of strategies to reduce antimicrobial use, there is a need for novel strategies. Traditional, Complementary, and Integrative Healthcare (TCIH) provides strategies and solutions that contribute to reducing (inappropriate) antimicrobial use, preventing or treating infections in both human and veterinary medicine, and may contribute to promoting the health/resilience of humans and animals and reducing AMR. The aims of this study were to present the core results of a global TCIH research agenda for AMR and its added value to two existing global AMR research agendas published in 2023. Methods: A survey, interviews, and consensus meetings among network members, as an adapted version of the nominal group technique, were executed to develop the global TCIH research agenda. A comparison of the global TCIH research agenda with the two existing global AMR research agendas was performed. The TCIH additions to these two existing global AMR research agendas were determined. Results: The global TCIH research agenda adds to 19 of 40 research priorities of the World Health Organization (WHO) AMR research agenda 2023 and three of the five pillars of the WHO/Food and Agriculture Organization of the United Nations (FAO)/United Nations Environment Programme (UNEP)/World Organisation for Animal Health (WOAH) research agenda 2023. In addition, the TCIH research agenda adds two new research themes with four new research priorities and three new research priorities to already existing themes of the two global AMR research agendas. Conclusions: The global TCIH research agenda fits with and adds to two global AMR research agendas and can be used as an additional strategy to reduce AMR and (inappropriate) use of antibiotics.
- Open Access
- 1 November 2024
- Published by Springer Nature in Applied Psychophysiology and Biofeedback
- Vol. 50 (1) , 79-93
Mobile Heart Rate Variability Biofeedback for Work-Related Stress in Employees and the Influence of Instruction Format (Digital or Live) on Training Outcome: A Non-Randomized Controlled Trial
Work-related stress is a major health issue in most industrialized countries. Heart rate variability biofeedback (HRV-BfB) can promote resilience and stress coping capacity. Mobile HRV-BfB could contribute to stress prevention in the workplace. Little is known about whether the type of training, with digital or live instruction, has an impact on the training outcome. This study analyzes the psychophysiological effects of four-week workplace resilience training with mobile HRV-BfB and the influence of instruction format (digital or live) on training success. This was a prospective, three-arm, non-randomized controlled trial with parallel group design. 73 employees of a bearing and seal manufacturer (58.9% male, 86.3% full-time employment, 67.1% office workers) attended resilience training with HRV-BfB, live (n = 24) or digital (n = 19) format, or served as waitlist controls (n = 30). HRV-BfB training spanned four weeks. Participants applied resilience techniques to increase HRV using visual biofeedback. Data were collected at baseline (T0), post-intervention (T1), and another four weeks later (T2). Primary outcome measure was the Burnout scale of the Copenhagen Psychosocial Questionnaire (COPSOQ) at T1. Secondary outcome measures included further COPSOQ scales, self-reported sleep quality (Pittsburgh Sleep Quality Index, PSQI), and HRV parameters. Burnout parameters decreased significantly in HRV-BfB and waitlist. The decrease (T0-T1 and T0-T2) showed higher effect sizes in HRV-BfB (Cohen’s d: 0.63; 0.69) than in waitlist (d: 0.27; 0.36). Sleep quality improved in HRV-BfB with small effect sizes (no change for waitlist). SDNN (standard deviation of beat-to-beat intervals) increased in HRV-BfB between T0 and T1 (d: 0.23;). In subgroup analysis, digital reached higher effect sizes for improvement in burnout (d: 0.87; 0.92) and sleep quality (d: 0.59; 0.64) than live learning (burnout: d: 0.43; 0.51; sleep quality: d: 0.28; 0.22). HRV-analysis revealed no differences between subgroups. Four-week mobile HRV-BfB resilience training reduced stress and burnout symptoms in employees. No significant differences were found between HRV-BfB digital or live. Hence, companies should choose the approach that fits their company profile or, if possible, offer both formats to accommodate the different needs of employees. However, findings were nonhomogeneous and should be verified by further studies. Trial Registration: ClinicalTrials.gov, NCT04897165, 05/18/2021, retrospectively registered.
- 1 November 2024
- Published by Springer Nature in Applied Psychophysiology and Biofeedback
- Vol. 50 (1) , 79-93
Open AccessMobile Heart Rate Variability Biofeedback for Work-Related Stress in Employees and the Influence of Instruction Format (Digital or Live) on Training Outcome: A Non-Randomized Controlled Trial
Work-related stress is a major health issue in most industrialized countries. Heart rate variability biofeedback (HRV-BfB) can promote resilience and stress coping capacity. Mobile HRV-BfB could contribute to stress prevention in the workplace. Little is known about whether the type of training, with digital or live instruction, has an impact on the training outcome. This study analyzes the psychophysiological effects of four-week workplace resilience training with mobile HRV-BfB and the influence of instruction format (digital or live) on training success. This was a prospective, three-arm, non-randomized controlled trial with parallel group design. 73 employees of a bearing and seal manufacturer (58.9% male, 86.3% full-time employment, 67.1% office workers) attended resilience training with HRV-BfB, live (n = 24) or digital (n = 19) format, or served as waitlist controls (n = 30). HRV-BfB training spanned four weeks. Participants applied resilience techniques to increase HRV using visual biofeedback. Data were collected at baseline (T0), post-intervention (T1), and another four weeks later (T2). Primary outcome measure was the Burnout scale of the Copenhagen Psychosocial Questionnaire (COPSOQ) at T1. Secondary outcome measures included further COPSOQ scales, self-reported sleep quality (Pittsburgh Sleep Quality Index, PSQI), and HRV parameters. Burnout parameters decreased significantly in HRV-BfB and waitlist. The decrease (T0-T1 and T0-T2) showed higher effect sizes in HRV-BfB (Cohen’s d: 0.63; 0.69) than in waitlist (d: 0.27; 0.36). Sleep quality improved in HRV-BfB with small effect sizes (no change for waitlist). SDNN (standard deviation of beat-to-beat intervals) increased in HRV-BfB between T0 and T1 (d: 0.23;). In subgroup analysis, digital reached higher effect sizes for improvement in burnout (d: 0.87; 0.92) and sleep quality (d: 0.59; 0.64) than live learning (burnout: d: 0.43; 0.51; sleep quality: d: 0.28; 0.22). HRV-analysis revealed no differences between subgroups. Four-week mobile HRV-BfB resilience training reduced stress and burnout symptoms in employees. No significant differences were found between HRV-BfB digital or live. Hence, companies should choose the approach that fits their company profile or, if possible, offer both formats to accommodate the different needs of employees. However, findings were nonhomogeneous and should be verified by further studies. Trial Registration: ClinicalTrials.gov, NCT04897165, 05/18/2021, retrospectively registered.
- Open Access
- 5 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Association Between Applying a Mobile Health Decision Aid and Education Application and Caregivers' Behavioral Change in the Management of Child Febrile Illnesses - Use of Antibiotics, Antipyretics, and the Healthcare System: A Single-Arm Prospective Pre-Post Intervention Study (Preprint)
BACKGROUND Feverish illnesses are common among children, presenting a management challenge for caregivers. Despite evidence supporting beneficial immunological effects, the practical implementation of this knowledge is lacking and a prevailing negative attitude towards fever persists. The overuse of antipyretics and antibiotics in general pediatric practice, along with the associated risk of antimicrobial resistance, underscores critical considerations in healthcare. OBJECTIVE The goal of this study was to evaluate the mHealth intervention FeverFriend, a personalized decision aid mobile phone application connected with a knowledge base. The aim was to enhance health literacy to improve health literacy among caregivers of children with feverish illnesses and to teach fever management adherent to the NICE (2021) guideline. It was hypothesized, that the users following the app usage would administer less antipyretics, antibiotics, and seek less frequent consultations with doctors compared to their practices before using the app. METHODS This study had a single-arm, prospective, pre-post evaluation design. Eligible participants were caregivers of healthy children under 18 residing in Hungary. Entering the study, participants provided demographic, anthropometric information and responded to premeasurements related to the use of 1) antibiotics, 2) antipyretics, and the 3) healthcare system (visiting a doctor) due to feverish illnesses. The prospective intervention involved the use of the FeverFriend mHealth application, followed by post-measurements on the same three dimensions, among other feverish symptoms. We assessed sample coverage by examining basic caregiver-reported sociodemographic and anthropometric measures using chi-square test for independence. We captured within-patient change applying paired binary McNemar's tests for the three user-reported baseline and post-intervention outcome measures during the 35-month period analyzed. RESULTS Caregivers enrolled a total of 22.219 healthy children with average age 3 years 1 month (SD 3.28) demonstrating good coverage of the population on gender (female 48.22% (10.714/22.219; χ21=2.517, P=.64) and number of siblings (1.67, SD 0.88; χ24=11.45, P=.56). A total of 12.948 feverish illnesses were reported, of which 4.927 (38.05%, 4.927/12.948) were reviewed in detail providing post-measurements. The outcomes of the first illness reviews per each patient (n=1.934) were utilized to ensure consistent intervention exposure for all patients. Our results support the hypotheses: after completing the mHealth intervention, caregivers administered significantly less antipyretics (McNemar χ21=13.79), antibiotics (McNemar χ21=8.17) and consult less often (McNemar χ21=128.84) with doctors (all P values <.005). CONCLUSIONS This study provides preliminary evidence that the FeverFriend mHealth intervention has the potential to reduce administration of antipyretics, antibiotics among children with feverish illnesses and users exhibited a decreased frequency of doctor visits compared to their practices before using the app. Future research should incorporate randomized trials to confirm causality and the multivariate analysis of the secondary outcome measures of the app on symptoms and parental confidence. CLINICALTRIAL ClinicalTrials.gov NCT04633603; https://clinicaltrials.gov/study/NCT04633603
- 5 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAssociation Between Applying a Mobile Health Decision Aid and Education Application and Caregivers' Behavioral Change in the Management of Child Febrile Illnesses - Use of Antibiotics, Antipyretics, and the Healthcare System: A Single-Arm Prospective Pre-Post Intervention Study (Preprint)
BACKGROUND Feverish illnesses are common among children, presenting a management challenge for caregivers. Despite evidence supporting beneficial immunological effects, the practical implementation of this knowledge is lacking and a prevailing negative attitude towards fever persists. The overuse of antipyretics and antibiotics in general pediatric practice, along with the associated risk of antimicrobial resistance, underscores critical considerations in healthcare. OBJECTIVE The goal of this study was to evaluate the mHealth intervention FeverFriend, a personalized decision aid mobile phone application connected with a knowledge base. The aim was to enhance health literacy to improve health literacy among caregivers of children with feverish illnesses and to teach fever management adherent to the NICE (2021) guideline. It was hypothesized, that the users following the app usage would administer less antipyretics, antibiotics, and seek less frequent consultations with doctors compared to their practices before using the app. METHODS This study had a single-arm, prospective, pre-post evaluation design. Eligible participants were caregivers of healthy children under 18 residing in Hungary. Entering the study, participants provided demographic, anthropometric information and responded to premeasurements related to the use of 1) antibiotics, 2) antipyretics, and the 3) healthcare system (visiting a doctor) due to feverish illnesses. The prospective intervention involved the use of the FeverFriend mHealth application, followed by post-measurements on the same three dimensions, among other feverish symptoms. We assessed sample coverage by examining basic caregiver-reported sociodemographic and anthropometric measures using chi-square test for independence. We captured within-patient change applying paired binary McNemar's tests for the three user-reported baseline and post-intervention outcome measures during the 35-month period analyzed. RESULTS Caregivers enrolled a total of 22.219 healthy children with average age 3 years 1 month (SD 3.28) demonstrating good coverage of the population on gender (female 48.22% (10.714/22.219; χ21=2.517, P=.64) and number of siblings (1.67, SD 0.88; χ24=11.45, P=.56). A total of 12.948 feverish illnesses were reported, of which 4.927 (38.05%, 4.927/12.948) were reviewed in detail providing post-measurements. The outcomes of the first illness reviews per each patient (n=1.934) were utilized to ensure consistent intervention exposure for all patients. Our results support the hypotheses: after completing the mHealth intervention, caregivers administered significantly less antipyretics (McNemar χ21=13.79), antibiotics (McNemar χ21=8.17) and consult less often (McNemar χ21=128.84) with doctors (all P values <.005). CONCLUSIONS This study provides preliminary evidence that the FeverFriend mHealth intervention has the potential to reduce administration of antipyretics, antibiotics among children with feverish illnesses and users exhibited a decreased frequency of doctor visits compared to their practices before using the app. Future research should incorporate randomized trials to confirm causality and the multivariate analysis of the secondary outcome measures of the app on symptoms and parental confidence. CLINICALTRIAL ClinicalTrials.gov NCT04633603; https://clinicaltrials.gov/study/NCT04633603
- Open Access
The Effect of Aviva Exercise Intervention on Pain Level and Body Awareness in Women with Primary Dysmenorrhea
Background and Objective: Primary dysmenorrhea (PD) is one of the most common clinical disorders in women of reproductive age. Our aim was to examine whether a twice-weekly thirty-minute Aviva exercise intervention could result in improvements in pain level and body awareness in patients with PD. Materials and Methods: In our prospective observational trial, the observation period included two consecutive menstrual cycles and the period of the next menstrual bleeding. The first menstrual bleeding period was the first measurement time (T1), the second was the second measurement time (T2), and the third was the third measurement time (T3) in a total of 78 volunteers. The primary endpoint was the change in the level of menstrual pain according to the Numeric Rating Scale (NRS) questionnaire between the intervention group (IG) and the control group (CG) at T1, T2, and T3. In this study, the secondary outcomes were the differences between the IG and CG regarding the different subscales of the Hungarian version of the Body Awareness Questionnaire (BAQ-H) at T1, T2, and T3; the Borg scale results of the IG; and adherence to the intervention. Statistical tests such as independent-sample t-tests, chi-square tests, Pearson’s linear correlation coefficient, and repeated-measure ANCOVA were used for the analyses. Results: In total, 78 volunteers were enrolled: 40 persons in the IG and 38 in the CG. There was a significant change in the level of menstruation pain according to the NRS questionnaire between the IG and CG (p < 0.001). There was no significant difference between the IG and CG regarding the different subscales of the BAQ-H. Only in the case of the “Note responses or changes in body process” subscale of the BAQ-H was there a trend-like effect from the Aviva exercises (p = 0.086). Conclusions: The Aviva exercise could contribute to pain relief from PD. Regarding body awareness, no significant difference was found between the two groups. Due to the short detection period and prospective observational design, our results are preliminary and need to be confirmed in larger clinical trials.
Open AccessThe Effect of Aviva Exercise Intervention on Pain Level and Body Awareness in Women with Primary Dysmenorrhea
Background and Objective: Primary dysmenorrhea (PD) is one of the most common clinical disorders in women of reproductive age. Our aim was to examine whether a twice-weekly thirty-minute Aviva exercise intervention could result in improvements in pain level and body awareness in patients with PD. Materials and Methods: In our prospective observational trial, the observation period included two consecutive menstrual cycles and the period of the next menstrual bleeding. The first menstrual bleeding period was the first measurement time (T1), the second was the second measurement time (T2), and the third was the third measurement time (T3) in a total of 78 volunteers. The primary endpoint was the change in the level of menstrual pain according to the Numeric Rating Scale (NRS) questionnaire between the intervention group (IG) and the control group (CG) at T1, T2, and T3. In this study, the secondary outcomes were the differences between the IG and CG regarding the different subscales of the Hungarian version of the Body Awareness Questionnaire (BAQ-H) at T1, T2, and T3; the Borg scale results of the IG; and adherence to the intervention. Statistical tests such as independent-sample t-tests, chi-square tests, Pearson’s linear correlation coefficient, and repeated-measure ANCOVA were used for the analyses. Results: In total, 78 volunteers were enrolled: 40 persons in the IG and 38 in the CG. There was a significant change in the level of menstruation pain according to the NRS questionnaire between the IG and CG (p < 0.001). There was no significant difference between the IG and CG regarding the different subscales of the BAQ-H. Only in the case of the “Note responses or changes in body process” subscale of the BAQ-H was there a trend-like effect from the Aviva exercises (p = 0.086). Conclusions: The Aviva exercise could contribute to pain relief from PD. Regarding body awareness, no significant difference was found between the two groups. Due to the short detection period and prospective observational design, our results are preliminary and need to be confirmed in larger clinical trials.
- Open Access
- 10 November 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (22) , 7021
The Effect of Exercise on Pulsatility Index of Uterine Arteries and Pain in Primary Dysmenorrhea
Background: Primary dysmenorrhea (PD) is one of the most common diseases in women of reproductive age. Our aim was to examine whether a twice-weekly thirty-minute exercise intervention could result in a difference in the pulsatility index (PI) of the uterine arteries (UAs) and level of menstrual pain in patients with PD. Methods: In our prospective observational trial, the observation period included one spontaneous menstrual cycle and the consecutive time of the next menstruation of all participants, aged 18–44, with no extensive sports experience. In total, 73 volunteers were enrolled: 38 persons in the intervention group (IG) and 35 in the control group (CG). The intervention program was accompanied by music, performed in groups under the supervision of a qualified instructor in Hungary. The primary outcome was the difference between the IG and CG regarding the PI values of UAs at the 1st and the 2nd ultrasound (US) Doppler flowmetry. The secondary outcome was the difference between the IG and CG regarding the PI of UAs and menstrual pain measured by using the Numeric Rating Scale and adherence to the intervention. Statistical tests such as an independent-samples t-test, chi-square test, Mann–Whitney test and analysis of covariance (ANCOVA) were used during the analyses. Results: Examining the mean of the PI of UAs in the IG and the CG at the 1st and the 2nd US measurement, a significant difference was found in the change in the measured value (Z = −2.545; p = 0.011). The IG showed a significantly higher increase in the mean of the PI of UAs (Median = 0.825) than the CG (Median = 0.130). The difference in the PI of the UAs of the IG and the CG is not related to the level of pain in any group (p = 0.336) and not related to the whole sample (p = 0.354); furthermore, the level of pain did not significantly differ between the two groups. Conclusions: Our study is the first to document the significant effects of mild-to-moderate exercise training on the change in the PI of the UAs in individuals with PD. The IG had a reduced blood flow due to circulatory redistribution after exercise. The level of menstrual pain of primary dysmenorrhea patients is independent of the level of blood circulation regarding the PI of the UAs. Randomized controlled studies with more participants and a longer research period are needed to confirm our findings regarding the association between regular exercise and the PI of UAs. The study was registered at clinicaltrials.gov: NCT04618172.
- 10 November 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (22) , 7021
Open AccessThe Effect of Exercise on Pulsatility Index of Uterine Arteries and Pain in Primary Dysmenorrhea
Background: Primary dysmenorrhea (PD) is one of the most common diseases in women of reproductive age. Our aim was to examine whether a twice-weekly thirty-minute exercise intervention could result in a difference in the pulsatility index (PI) of the uterine arteries (UAs) and level of menstrual pain in patients with PD. Methods: In our prospective observational trial, the observation period included one spontaneous menstrual cycle and the consecutive time of the next menstruation of all participants, aged 18–44, with no extensive sports experience. In total, 73 volunteers were enrolled: 38 persons in the intervention group (IG) and 35 in the control group (CG). The intervention program was accompanied by music, performed in groups under the supervision of a qualified instructor in Hungary. The primary outcome was the difference between the IG and CG regarding the PI values of UAs at the 1st and the 2nd ultrasound (US) Doppler flowmetry. The secondary outcome was the difference between the IG and CG regarding the PI of UAs and menstrual pain measured by using the Numeric Rating Scale and adherence to the intervention. Statistical tests such as an independent-samples t-test, chi-square test, Mann–Whitney test and analysis of covariance (ANCOVA) were used during the analyses. Results: Examining the mean of the PI of UAs in the IG and the CG at the 1st and the 2nd US measurement, a significant difference was found in the change in the measured value (Z = −2.545; p = 0.011). The IG showed a significantly higher increase in the mean of the PI of UAs (Median = 0.825) than the CG (Median = 0.130). The difference in the PI of the UAs of the IG and the CG is not related to the level of pain in any group (p = 0.336) and not related to the whole sample (p = 0.354); furthermore, the level of pain did not significantly differ between the two groups. Conclusions: Our study is the first to document the significant effects of mild-to-moderate exercise training on the change in the PI of the UAs in individuals with PD. The IG had a reduced blood flow due to circulatory redistribution after exercise. The level of menstrual pain of primary dysmenorrhea patients is independent of the level of blood circulation regarding the PI of the UAs. Randomized controlled studies with more participants and a longer research period are needed to confirm our findings regarding the association between regular exercise and the PI of UAs. The study was registered at clinicaltrials.gov: NCT04618172.
- Open Access
- 5 February 2023
- Published by Akademiai Kiado Zrt. in Orvosi Hetilap
- Vol. 164 (5) , 179-185
A láz kezelésének modern szemléletéről a LázBarátTM program első eredményeinek fényében
Bevezetés: A gyermekkori láz pozitív hatásáról mára számos élettani, kórélettani és klinikai bizonyítékkal rendelkezünk. A lázhoz fűződő viszonyulás a köztudatban mégis tartósan negatívvá vált. A szociológiai kutatások ezt több tényezőre vezetik vissza: az indokolatlan félelemre, a segítségkereső viselkedésre, a tünetmentességre és közérzetjavításra törekvés komplex viselkedési mintázatára. A szemlélet változásának egyik kulcsa a legújabb kutatások fényében összefügg az egészségügyi dolgozók és a laikusok ez irányú tájékozottságának és egészségértésének változásával. Ebben a fiatal, médiahasználó generáció szerepe meghatározó. Célkitűzés: Egy olyan, hosszú távú kutatás létrehozása, melynek során médiaalapú „e-health” eszközök segítségével a gyógyszerhasználat (antipiretikumok és antibiotikumok), valamint az orvosi konzultációk száma csökkenthető, és a lázhoz való hozzáállás változtatható. Módszer: Megfigyeléses, adaptív, prospektív kohorszvizsgálatot indítottunk. A vizsgált intervenció egy nyilvánosan hozzáférhető applikáció és a kapcsolt ismeretterjesztő Tudástár. A gondozók önbevallással szolgáltatott adatait gyűjtjük. Az applikáció ezek figyelembevételével differenciáldiagnosztikai algoritmus alapján döntéstámogató állapotbesorolást nyújt. Eredmények: 1) A szakértő partnerek 100%-os konszenzussal Delfi-folyamat során határozták meg az applikációban rögzítésre kerülő paramétereket, elsődleges és másodlagos kritériumokat, valamint a vizsgálat adatgyűjtési és adatfeldolgozási módszertanát. 2) A rendelkezésre álló hazai és nemzetközi irányvonalak alapján a fenti paraméterekből hoztuk létre az állapotértékelési, döntéstámogató algoritmust, mely hosszú távon gépi tanulás kiindulópontja lehet. 3) Kiértékeltük a 2020. 11. 01-től 2022. 06. 15-ig terjedő időszak demográfiai, lázas eseményekhez fűződő és a lázcsillapítók használatát érintő alapadatokat. Következtetés: A LázBarátTM projekt a lázas gyermekek és felnőttek ellátása terén a bizonyítékokon alapuló modern lázmenedzsmenttel hozzájárulhat a fennálló egészségügyi rendszer medikalizációs és ellátási terheinek csökkentéséhez. A LázBarátTM program cél szerinti viselkedésváltozást befolyásoló hatását további adatfeldolgozásnak kell vizsgálnia. Orv Hetil. 2023; 164(5): 179–185.
- 5 February 2023
- Published by Akademiai Kiado Zrt. in Orvosi Hetilap
- Vol. 164 (5) , 179-185
Open AccessA láz kezelésének modern szemléletéről a LázBarátTM program első eredményeinek fényében
Bevezetés: A gyermekkori láz pozitív hatásáról mára számos élettani, kórélettani és klinikai bizonyítékkal rendelkezünk. A lázhoz fűződő viszonyulás a köztudatban mégis tartósan negatívvá vált. A szociológiai kutatások ezt több tényezőre vezetik vissza: az indokolatlan félelemre, a segítségkereső viselkedésre, a tünetmentességre és közérzetjavításra törekvés komplex viselkedési mintázatára. A szemlélet változásának egyik kulcsa a legújabb kutatások fényében összefügg az egészségügyi dolgozók és a laikusok ez irányú tájékozottságának és egészségértésének változásával. Ebben a fiatal, médiahasználó generáció szerepe meghatározó. Célkitűzés: Egy olyan, hosszú távú kutatás létrehozása, melynek során médiaalapú „e-health” eszközök segítségével a gyógyszerhasználat (antipiretikumok és antibiotikumok), valamint az orvosi konzultációk száma csökkenthető, és a lázhoz való hozzáállás változtatható. Módszer: Megfigyeléses, adaptív, prospektív kohorszvizsgálatot indítottunk. A vizsgált intervenció egy nyilvánosan hozzáférhető applikáció és a kapcsolt ismeretterjesztő Tudástár. A gondozók önbevallással szolgáltatott adatait gyűjtjük. Az applikáció ezek figyelembevételével differenciáldiagnosztikai algoritmus alapján döntéstámogató állapotbesorolást nyújt. Eredmények: 1) A szakértő partnerek 100%-os konszenzussal Delfi-folyamat során határozták meg az applikációban rögzítésre kerülő paramétereket, elsődleges és másodlagos kritériumokat, valamint a vizsgálat adatgyűjtési és adatfeldolgozási módszertanát. 2) A rendelkezésre álló hazai és nemzetközi irányvonalak alapján a fenti paraméterekből hoztuk létre az állapotértékelési, döntéstámogató algoritmust, mely hosszú távon gépi tanulás kiindulópontja lehet. 3) Kiértékeltük a 2020. 11. 01-től 2022. 06. 15-ig terjedő időszak demográfiai, lázas eseményekhez fűződő és a lázcsillapítók használatát érintő alapadatokat. Következtetés: A LázBarátTM projekt a lázas gyermekek és felnőttek ellátása terén a bizonyítékokon alapuló modern lázmenedzsmenttel hozzájárulhat a fennálló egészségügyi rendszer medikalizációs és ellátási terheinek csökkentéséhez. A LázBarátTM program cél szerinti viselkedésváltozást befolyásoló hatását további adatfeldolgozásnak kell vizsgálnia. Orv Hetil. 2023; 164(5): 179–185.
- Open Access
- 15 November 2022
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 71, 102902
Proctoclysis for rehydration in children – A scoping review and a pilot survey among medical doctors
- 15 November 2022
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 71, 102902
Open AccessProctoclysis for rehydration in children – A scoping review and a pilot survey among medical doctors
- Open Access
- 4 November 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (21) , 14502
Parental Confidence in Relation to Antipyretic Use, Warning Signs, Symptoms and Well-Being in Fever Management—Results from an App-Based Registry
Parents’ confidence regarding their children’s fever is a key factor in its management and there is still unnecessary anxiety and associated antipyretic overuse. The FeverApp application collects naturalistic real-time data on febrile infections and educates parents on fever management. Logistic regression examined the associations between (1) parental confidence and (2) antipyretics use with fever relevant parameters. First entry data of 3721 children (mean age 21 months; SD 22.97) was assessed. A total of 58.0% of parents felt confident upon first fever documentation. Warning signs [OR = 0.49, 95% CI: 0.40–0.61], dehydration [OR = 0.65, 95% CI: 0.52–0.81], fever [OR = 0.67, 95% CI: 0.57–0.80] and having a female child [OR = 0.77, 95% CI: 0.66–0.90] had the highest negative association with parental confidence. Antipyretics were used initially in 14.7% of children. Fever had the highest positive [OR = 2.58, 95% CI: 1.89–3.50] and well-being the highest negative association with antipyretic use [OR = 0.37, 95% CI: 0.22–0.63). In the first entry data, parental confidence was related to children’s health condition in a reasonable medical manner. The use of antipyretics was mostly associated with febrile temperature, but also low well-being. Thus, associations were partly in accordance with recent guidelines.
- 4 November 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (21) , 14502
Open AccessParental Confidence in Relation to Antipyretic Use, Warning Signs, Symptoms and Well-Being in Fever Management—Results from an App-Based Registry
Parents’ confidence regarding their children’s fever is a key factor in its management and there is still unnecessary anxiety and associated antipyretic overuse. The FeverApp application collects naturalistic real-time data on febrile infections and educates parents on fever management. Logistic regression examined the associations between (1) parental confidence and (2) antipyretics use with fever relevant parameters. First entry data of 3721 children (mean age 21 months; SD 22.97) was assessed. A total of 58.0% of parents felt confident upon first fever documentation. Warning signs [OR = 0.49, 95% CI: 0.40–0.61], dehydration [OR = 0.65, 95% CI: 0.52–0.81], fever [OR = 0.67, 95% CI: 0.57–0.80] and having a female child [OR = 0.77, 95% CI: 0.66–0.90] had the highest negative association with parental confidence. Antipyretics were used initially in 14.7% of children. Fever had the highest positive [OR = 2.58, 95% CI: 1.89–3.50] and well-being the highest negative association with antipyretic use [OR = 0.37, 95% CI: 0.22–0.63). In the first entry data, parental confidence was related to children’s health condition in a reasonable medical manner. The use of antipyretics was mostly associated with febrile temperature, but also low well-being. Thus, associations were partly in accordance with recent guidelines.